We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Januvia

ACNU Feasibility

View full report
ExcellentJanuvia is an oral diabetes tablet requiring careful monitoring due to serious side effects and dose adjustments for kidney function. It has low misuse risk, simple dosing, but needs ongoing medical oversight to manage interactions, hypoglycemia, and long-term efficacy.

ACNU Feasibility Scorecard

Chart with 11 data points.
Januvia
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.